Xperiome™ Labs

Learn how we turn patient engagement into insight using the Xperiome platform.


Learn about the research studies we conduct with commercial and academic partners, and the clinical trials we support for pharmaceutical sponsors.

A Raremark study: What do you think about your sickle cell treatment(s)?
This study aims to learn what people with sickle cell actually think about taking the newer sickle cell medications – Adakveo (crizanlizumab), Endari (L-glutamine), and Oxbryta (voxelotor) – and see how they compare with the older drug, hydroxyurea. This is not like other studies that may only focus on following doctors’ orders.

Anti-AChR antibody-positive generalized myasthenia gravis clinical research study
This placebo-controlled Phase 3 study is testing an investigational medicine called ravulizumab-cwvz, also known in this study as ALXN1210, on adults with anti-AChR antibody-positive, generalized myasthenia gravis (gMG).

Generalized myasthenia gravis (gMG) clinical research study (ASCEND-MG)
ASCEND-MG is a randomized, placebo-controlled study, testing an investigational medicine called RVT-1401 on adults with generalized myasthenia gravis (gMG).

Case studies

Discover how we’re making our mark in research and accelerating the development and reach of new treatments.

Get in touch

Interested in working with us? we’d love to hear from you. Please use the form below to provide us with a few details and we’ll get back in touch with you.

All fields required
Maximum 300 characters

United States office

Five Cowboys Way

Suite 300

Frisco TX 75034

+1 972-382-7227

United Kingdom office

Kemp House

152-160 City Road

London EC1V 2NX

+44 20 3920 9880